COVID-19

The European regulator evaluates the effectiveness of a booster with the anti-Covid Johnson & Johnson vaccine

November 22, 2021

15:42

The EMA is currently evaluating the efficacy of a Johnson & Johnson single-dose Covid vaccine booster.

The European Medicines Agency (EMA) is evaluating a request from the Johnson & Johnson laboratory to allow the injection of a booster dose with the vaccine it has designed against Covid-19 to people aged at least 18 years in the EU.

If the EMA gives the green light, it will be the third vaccine, after those from Pfizer / BioNTech and Moderna, that can be used in the EU as a booster in adults. It will then be administered at least two months after the administration of the single dose of Johnson & Johnson Janssen. A result is “expected in the coming weeks,” the European regulator said.

Read also

The data analyzed by the EMA will include the results of more than 14,000 adults who received a second dose of the Janssen Covid-19 vaccine or a placebo, the agency said. Remember that the EMA has approved the use of four covid vaccines in total: those from Pfizer / BioNTech and Moderna, which are based on messenger RNA technology, and those from AstraZeneca and Johnson & Johnson, which are based on vector technology. virus.

WeaPlay, WordPress Theme, Business Consulting Nulled, Avada 7.4 Nulled, Newspaper – News & WooCommerce WordPress Theme, Nulledfire, Elementor Pro Weadown, Astra Pro Nulled, Plugins, Rank Math Seo Pro Weadown, Woodmart Theme Nulled, Elementor Pro Weadown,Woodmart Theme Nulled, Wordfence Premium Nulled, Flatsome Nulled, Yoast Nulled, Woocommerce Custom Product Ad, Jannah Nulled, Dokan Pro Nulled, Fs Poster Plugin Nulled, Jnews 8.1.0 Nulled, PW WooCommerce Gift Cards Pro Nulled, Newspaper 11.2, Premium Addons for Elementor, Slider Revolution Nulled, Wpml Nulled, PHP Script, WP Reset Pro, Consulting 6.1.4 Nulled

Back to top button